The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...
4don MSN
Georgia bill would allow pharmacists to prescribe PrEP in effort to expand HIV prevention access
A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that ...
If the Trump administration goes through with a plan to make major cuts to the Centers for Disease Control and Prevention’s HIV division, Georgia and other states in the Southeast would struggle to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results